Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer

AIM: To determine the efficacy of bevacizumab in patients with metastatic colorectal cancer (MCRC) who have failed prior chemotherapy without bevacizumab. METHODS: Between March 2002 and June 2010, 40 patients in South Korea with MCRC who were treated with bevacizumab plus chemotherapy as a second o...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Park, Lee Chun, Lee, Ho Sup, Shin, Seong Hoon, Park, Seun Ja, Park, Moo In, Oh, Sung Yong, Kwon, Hyuk Chan, Baek, Jin ho, Choi, Young Jin, Kang, Myoung Joo, Kim, Yang Soo
格式: Artigo
語言:Inglês
出版: Baishideng Publishing Group Co., Limited 2012
主題:
Brief Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3296985/
https://ncbi.nlm.nih.gov/pubmed/22416186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v18.i10.1104
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍